AI assistant
Sending…
BioCardia, Inc. — Director's Dealing 2020
May 4, 2020
35081_dirs_2020-05-04_a3ee2eb0-89ed-41d2-95ea-86ce5315dca1.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BioCardia, Inc. (BCDA;BCDAW)
CIK: 0000925741
Period of Report: 2020-04-30
Reporting Person: MOYES JAY M (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-04-30 | Common Stock | A | 20250 | — | Acquired | 24211 | Direct |
| 2020-04-30 | Common Stock | A | 3750 | — | Acquired | 27961 | Direct |
Footnotes
F1: The award relates to vested restricted stock units ("RSUs") granted April 30, 2020, each of which represents a contingent right to receive one share of the Issuer's common stock, but for which delivery of common stock will occur the earliest of (i) two years from the date of grant, (ii) the date the director ceases to be a service provider, or (iii) such other date as the administrator determines under the Issuer's 2016 Equity Incentive Plan.
More from BioCardia, Inc.
Regulatory Filings
2026
May 28
Regulatory Filings
2026
May 21
Regulatory Filings
2026
May 15
Interim / Quarterly Report
2026
May 15
Regulatory Filings
2026
May 8
Regulatory Filings
2026
Apr 28
Regulatory Filings
2026
Apr 20
Regulatory Filings
2026
Apr 15
Regulatory Filings
2026
Apr 2
Director's Dealing
2026
Mar 27